Novartis is a global healthcare company based in Switzerland that provides solutions to the evolving needs of patients worldwide.● Contribute strategic, medical, clinical and scientific guidance on Multiple Sclerosis to all allied departments● Ensure optimal collaboration with Local, Regional and Global Teams● Interact proactively with Scientific Operations, MSLs and marketing

Galderma is the medical solutions business within Nestlé Skin Health. It provides prescription drugs and aesthetics solutions, going beyond treating skin problems to also protect and enhance healthy skin, treat compromised skin and rejuvenate aging skin.● Soft power: Engage internal & external stakeholders towards common goals like the Galderma SKINPACT Awards creating shared value / social responsibility initiative● Staff: Manage, coach and develop MPR Manager● Lead: External stakeholder management (dermatology societies, patient organizations and funding requests)● Patient Centricity: Sought how Galderma Intl. can be Patient-Centric● Budget: Managed a budget of 500 - 1,000K €RESULTS: Improved Galderma International’s reputation and relationship with the medical community and patient organizations. Increased 2 to 5 fold the number of SKINPACT projects submitted.

TEVA Europe markets a range of specialty medicines, generic medicines, active pharmaceutical ingredients (API) and OTC products. My focus was the competitive field of Multiple Sclerosis (Neurology).● EU MSLs: Imported and applied the “Data Crunch”; strategic and development meetings for/by MSLs in collaboration with the US team● Congress Coverage: Co-organized with/for US & EU MSLs● CME: Led the development of educational programs for HCPs and Satellite Symposia at International congresses● Life Cycle Management: Organized multistakeholder meetings (industry, academia, payers, regulators, patient advocacy) and advisory boards● External stakeholders: Led the interactions with Neurology societies and Patient Organizations● Publication Plan: Consolidated the EU plan into the Global plan + led a number of review publicationsRESULTS: Teva Europe strongly established as a respectful and modern partner for HCPs and patient associations in Europe

A global leader in treatments for disorders of the central nervous system (CNS), Teva provides products to treat patients with neurological and neurodegenerative disorders, pain, and sleep disorders, in various countries around the world. Teva is also developing innovative solutions in headache and migraine, and socially responsible pain treatments.● KOL/EE Management: Rapidly developed working relations based on trust with French and International stakeholders● Staff presentations: Performed over 20 all over France in 2007● CME: Led and developed CME events (Neurologists & Nurses & printed supplements), satellite symposia and MS experts board meetings● Training: Train France sales reps & international new hires● Global initiatives: Contributed to Business Development, Publication Plan, IIT CommitteeRESULTS: Gained deep experience living and working internationally

TEVA Canada Innovation is a branded, innovative specialty medicines company.● Campaign: Scientifically led the development and communication of the neuroprotection campaign● Teamwork: Created and developed with US colleagues the “Data Crunch”, strategic and development meetings for/by MSLs● Training: Trained local Reps and MSLs + invited to contribute to US and Global trainings● Global: Active member of the Copaxone® Publication Plan Group and Business DevelopmentRESULTS: Rapidly transitioned from academia to industry and contributed to the blockbuster growth of Copaxone®